Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers June 24, 2017
Pharmacy Choice - News - Drug Delivery Systems - June 24, 2017

Pharmacy News

 Drug Delivery Systems
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 250     Next >>     Go To Page:

6/17/17 - FDA Reviewing ADS-5102, Possible 1st Treatment for Levodopa-induced Dyskinesia in Parkinsons [Sport360]
Adamas Pharmaceuticals, the treatments developer, has filed a New Drug Application for the use of ADS-5102 extended-release capsules to treat levodopa-induced dyskinesia jerky and involuntary movements in Parkinsons patients. The U.S. Food and Drug Administration has taken it under review and set Aug. 24 as a possible decision date. ADS-5102 reduce
6/16/17 - Adamis Pharmaceuticals Receives FDA Approval for Its Epinephrine Pre-Filled Syringe [Tehran Times (Iran)]
-Adamis Pharmaceuticals Corporation today announced that the U.S. Food and Drug Administration has approved Adamis EPINEPHRINE INJECTION, USP, 1:10 00 for the emergency treatment of allergic reactions including anaphylaxis. The FDA has also approved the PFS trade name of Symjepi. Dennis J. Carlo, President and CEO of Adamis, stated, We are very exc
6/16/17 - Aequus Advances Clinical Development of Transdermal Anti-Nausea Patch [Syrian Arab News Agency]
Aequus Pharmaceuticals Inc., a specialty pharmaceutical company with a focus on developing, advancing and promoting differentiated products, announced today that is has filed a Clinical Trial Application with Health Canada in preparation for a Proof of Concept clinical study for its long-acting transdermal anti-nausea patch, AQS1303, containing the
6/16/17 - Aurobindo Pharma gets USFDA nod for oral suspension [Tehran Times (Iran)]
Drug firm Aurobindo Pharma has received USFDA nod to make oral suspension used for controlling serum phosphorus in patients with chronic kidney disease on dialysis. The company has received final approval from the US Food and Drug Administration to manufacture Sevelamer Carbonate oral suspension, 0.8 gm and 2.4 gm, the drug maker said in a BSE fili
6/16/17 - Findings from University of Malaya Provide New Insights into Drug Delivery Systems (pH Sensitive Hydrogels in Drug Delivery: Brief History,...
According to news reporting out of Kuala Lumpur, Malaysia, by NewsRx editors, research stated, "Improving the safety efficacy ratio of existing drugs is a current challenge to be addressed rather than the development of novel drugs which involve much expense and time." Our news journalists obtained a quote from the research from the University of M
6/16/17 - Findings from University of Victoria Provide New Insights into Drug Delivery Systems (Controlling Structure and Function of Polymeric Drug Delivery...
Findings from University of Victoria Provide New Insights into Drug Delivery Systems. According to news reporting originating in Victoria, Canada, by NewsRx journalists, research stated, "We demonstrate control of multiscale structure and drug delivery function for paclitaxel- loaded polycaprolactone-block-poly polymeric nanoparticles via...
6/16/17 - Findings in the Area of Drug Delivery Systems Reported from University Medical Center of the Johannes Gutenberg University (Dendritic Mesoporous...
Findings in the Area of Drug Delivery Systems Reported from University Medical Center of the Johannes Gutenberg University. Financial supporters for this research include Cancer Council NSW, Collaborative Research Center, Deutsche Forschungsgemeinschaft, Helmut Jonuleit and Wolfgang Tremel, Center for Innovative and Emerging Materials, Cancer...
6/16/17 - Gilead submits drug application to FDA for HIV treatment [Sudan Tribune]
Gilead Sciences has submitted a new drug application to the US Food and Drug Administration for an investigational, once-daily single tablet regimen containing bictegravir, a novel investigational integrase strand transfer inhibitor, and emtricitabine/tenofovir alafenamide for the treatment of HIV-1 infection in adults. BIC/F/TAF has demonstrated..
6/16/17 - Implantable Drug Delivery Devices Market | Industry Research Report 2016-2023 Latest Added By DecisionDatabases
DecisionDatabases.com offers Implantable Drug Delivery Devices Market Research Report provide trends and future prospects for each application in terms of market size, share, trend, growth and forecast period 2016-2023. The global implantable drug de...
6/16/17 - Injectable Drug Delivery Market Report 2017 Global Analysis and Forecast to 2024
The new market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024. Global Injectable Drug Delivery Market, By Type (Devices{ Conventional Injection, Self-Injection}, Formulations{ Conventional Drug Delivery, Noble Drug Delivery, Long Acting Injection Formulations}, Applications
6/16/17 - Investigators at Panjab University Detail Findings in Drug Delivery Systems (Nanoporous metal organic frameworks as hybrid polymer-metal composites...
Our news journalists obtained a quote from the research from Panjab University, "The unique physical and chemical characteristics of MOFs have attracted wider attention from the scientific community, exploring their utility in the field of material science, biology, nanotechnology and drug delivery. For more information on this research see: Nanopo
6/16/17 - Investigators at University of Vienna Discuss Findings in Drug Delivery Systems [Poly - (L) - glutamic acid drug delivery system for the intravesical...
Investigators at University of Vienna Discuss Findings in Drug Delivery Systems. According to news reporting originating in Vienna, Austria, by NewsRx journalists, research stated, "In the management of bladder cancer, surgical resection of the tumour is usually followed by intravesical instillation of immunomodulatives and/or chemotherapeutics.
6/16/17 - Lannett Announces Approval For Amantadine Hydrochloride Capsules USP, 100 mg
Lannett Company, Inc. today announced that it received approval from the U.S. Food and Drug Administration of its Abbreviated New Drug Application for Amantadine Hydrochloride Capsules USP, 100 mg, the therapeutic equivalent to the reference standard drug, Amantadine Hydrochloride Capsules USP, 100 mg, of Sandoz Pharmaceuticals. For the 12 months
6/16/17 - LUPIN LAUNCHES ANTIDEPRESSANT TABLETS IN US
Lupin, the drug manufacturer, has launched its antidepressant Bupropion Hydrochloride extended release tablets in the USA. The company had received approval from the United States Food and Drug Administration to launch these drugs. The drugs are generic versions of Wellbutrin XL tablets of Valeant Pharmaceuticals North America LLC.
6/16/17 - Mylan Launches Generic Azilect Tablets
By a News Reporter-Staff News Editor at Drug Week Mylan N.V. announced the U.S. launch of Rasagiline Tablets, 0.5 mg and 1 mg, a generic version of the reference listed drug, Teva's Azilect Tablets. Rasagiline Tablets, 0.5 mg and 1 mg, had U.S. sales of approximately $343 million for the 12 months ending March 31, 2017, according to QuintilesI
6/16/17 - New Findings in Drug Delivery Systems Described from National Taiwan University of Science and Technology (Hydrophobic Drug-Loaded PEGylated Magnetic...
New Findings in Drug Delivery Systems Described from National Taiwan University of Science and Technology. According to news originating from Taipei, Taiwan, by NewsRx correspondents, research stated, "Less targeted and limited solubility of hydrophobic-based drug are one of the serious obstacles in drug delivery system. Our news journalists obtain
6/16/17 - Oral Vaccines Market Set to Surge Significantly During 20172025: Persistence Market Research
The global market for oral vaccines is primarily driven by increasing prevalence of infectious diseases in developing countries, bioterrorism, resistance to existing vaccines, etc.New York, NY 06/16/2017 In past few years, there has been tremendous increase in the demand for needle-free vaccines due to obvious choice to more comfortable oral
6/16/17 - Reports Outline Drug Delivery Systems Findings from Federal University of Pernambuco (Preparation and physicochemical characterization of binary...
Reports Outline Drug Delivery Systems Findings from Federal University of Pernambuco. According to news reporting originating from Recife, Brazil, by NewsRx correspondents, research stated, "This work aimed the evaluation of pH influence in the obtainment of composites from palygorskite and chitosan. Our news editors obtained a quote from the resea
6/16/17 - Researchers from VIT University Detail Findings in Arthritis (Targeted delivery of morin, a dietary bioflavanol encapsulated mannosylated liposomes...
By a News Reporter-Staff News Editor at Drug Week Research findings on Musculoskeletal Diseases and Conditions- Arthritis are discussed in a new report. According to news reporting out of Tamil Nadu, India, by NewsRx editors, research stated, "The purpose of the study was to develop a liposomal drug delivery system for morin, a dietary polyphenol
6/16/17 - Researchers Submit Patent Application, "A Pharmaceutical Oil-In-Water Nano-Emulsion", for Approval (USPTO 20170143627)
By a News Reporter-Staff News Editor at Drug Week From Washington, D.C., NewsRx journalists report that a patent application by the inventors Misra, Ambikanandan, filed on June 25, 2015, was made available online on June 1, 2017. No assignee for this patent application has been made. News editors obtained the following quote from the background i
6/16/17 - Xencor Presents Interim Data from an Ongoing, Open-label, Phase 2 Study of XmAb5871 in IgG4-Related Disease at EULAR 2017
Xencor, Inc., a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of autoimmune diseases, asthma and allergic diseases and cancer, today announced interim data from an ongoing, open-label, pilot Phase 2 study of XmAb 5871 in patients with active IgG4-Related Disease. The data were presented
6/15/17 - A Peek At Adamas Ahead Of FDA Approval
The FDA has twice previously rejected Adamas' product, once in March 2015 and once in June 2016. However, Adamas once again filed an NDA for the syringe in December after addressing concerns the FDA raised in the June rejection. The FDA could have ruled on the pen as early as Wednesday, according to RTTNews.
6/15/17 - Adamis Pharmaceuticals Receives FDA Approval for Its Epinephrine Pre-Filled Syringe
Adamis Pharmaceuticals Corporation today announced that the U.S. Food and Drug Administration has approved Adamis EPINEPHRINE INJECTION, USP, 1:10 00 for the emergency treatment of allergic reactions including anaphylaxis. The FDA has also approved the PFS trade name of Symjepi?. Dennis J. Carlo, President and CEO of Adamis, stated, We ar
6/15/17 - Aequus Advances Clinical Development of AQS1303
Aequus Pharmaceuticals filed a Clinical Trial Application with Health Canada for their upcoming clinical study for transdermal anti-nausea patch, AQS1303. Currently, the oral form of Diclegis is the only FDA approved medication for morning sickness in pregnant women and in 2015 reached sales in the United States of approximately U.S.
6/15/17 - Aequus Advances Clinical Development of Transdermal Anti-Nausea Patch
Aequus Pharmaceuticals Inc., a specialty pharmaceutical company with a focus on developing, advancing and promoting differentiated products, announced today that is has filed a Clinical Trial Application with Health Canada in preparation for a Proof of Concept clinical study for its long-acting transdermal anti-nausea patch, AQS1303, containing the
Articles(s): 1 - 25 of 250     Next >>     Go To Page:


© 2017 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Legal & Practical Issues in Compounding Pharmacy
This lesson is supported by:
RxSchool
Telepharmacy- Remote Delivery of Pharmacy Services
This lesson is supported by:
RxSchool
Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool
Drug Therapy Management Series Part III: Geriatric Disorders
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2017 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415